Diurnal hepatic CYP3A11 contributes to chronotoxicity of the pyrrolizidine alkaloid retrorsine in mice

References

• Buhler DR, Miranda CL, Kedzierski B, Reed RL. 1991. Mechanisms for pyrrolizidine alkaloid activation and detoxification. Adv Exp Med Biol. 283:597–603.
   PubMedGoogle Scholar
• Chen M, Guan B, Xu H, Yu F, Zhang T, Wu B. 2019. The molecular mechanism regulating diurnal rhythm of flavin-containing monooxygenase 5 in mouse liver. Drug Metab Dispos. 47(11):1333–1342.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou C, Zhang T, Wu B. 2020. Identification of rhythmic human CYPs and their circadian regulators using synchronized hepatoma cells. Xenobiotica. 50(9):1052–1063.
   PubMed Web of Science ®Google Scholar
• Chen X, Yu F, Guo X, Su C, Li SS, Wu B. 2021. Clock gene Bmal1 controls diurnal rhythms in expression and activity of intestinal carboxylesterase 1. J Pharm Pharmacol. 73(1):52–59.
   PubMed Web of Science ®Google Scholar
• Chen Z, Huo JR. 2010. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med. 68(6):252–260.
   PubMed Web of Science ®Google Scholar
• Chou MW, Fu PP. 2006. Formation of DHP-derived DNA adducts in vivo from dietary supplements and Chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids. Toxicol Ind Health. 22(8):321–327.
   PubMed Web of Science ®Google Scholar
• Dai J, Zhang F, Zheng J. 2010. Retrorsine, but not monocrotaline, is a mechanism-based inactivator of P450 3A4. Chem Biol Interact. 183(1):49–56.
   PubMed Web of Science ®Google Scholar
• Dibner C, Schibler U, Albrecht U. 2010. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 72:517–549.
   PubMed Web of Science ®Google Scholar
• Fu PP, Xia Q, Lin G, Chou MW. 2004. Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev. 36(1):1–55.
   PubMed Web of Science ®Google Scholar
• Gao H, Ruan JQ, Chen J, Li N, Ke CQ, Ye Y, Lin G, Wang JY. 2015. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. Drug Des Devel Ther. 9:4861–4868.
   PubMed Web of Science ®Google Scholar
• Guo D, Fu T, Nelson JA, Superina RA, Soriano HE. 2002. Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride. Transplantation. 73(11):1818–1824. 15
   PubMed Web of Science ®Google Scholar
• Hrushesky W. 1984. Chemotherapy timing: an important variable in toxicity and response. In: Perry MC, Yarbo JW, editors. Toxicity of chemotherapy. New York: Grune & Stratton; p. 449–477.
   Google Scholar
• Kasahara Y, Kiyatake K, Tatsumi K, Sugito K, Kakusaka I, Yamagata S, Ohmori S, Kitada M, Kuriyama T. 1997. Bioactivation of monocrotaline by P-450 3A in rat liver. J Cardiovasc Pharmacol. 30(1):124–129.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Bruguerolle B. 1994. Chronopharmacokinetics. Are they clinically relevant? Clin Pharmacokinet. 26(6):419–427.
   PubMed Web of Science ®Google Scholar
• Liang Q, Sheng Y, Jiang P, Ji L, Xia Y, Min Y, Wang Z. 2011. The gender-dependent difference of liver GSH antioxidant system in mice and its influence on isoline-induced liver injury. Toxicology. 280(1–2):61–69.
   PubMed Web of Science ®Google Scholar
• Lin G, Wang JY, Li N, Li M, Gao H, Ji Y, Zhang F, Wang H, Zhou Y, Ye Y, et al. 2011. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 54(4):666–673.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang S, Zhou Z, Guo L, Yu F, Wu B. 2019. Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. Commun Biol. 2:378.
   PubMed Web of Science ®Google Scholar
• Liu TY, Chen Y, Wang ZY, Ji LL, Wang ZT. 2010. Pyrrolizidine alkaloid isoline-induced oxidative injury in various mouse tissues. Exp Toxicol Pathol. 62(3):251–257.
   PubMedGoogle Scholar
• Martignoni M, Groothuis GM, de Kanter R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2(6):875–894.
   PubMed Web of Science ®Google Scholar
• Min DI, Chen HY, Lee MK, Ashton K, Martin MF. 1997. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients. Pharmacotherapy. 17(3):457–463.
   PubMed Web of Science ®Google Scholar
• Pang X, Tang C, Kong F, Chen M, Chen X. 2020. CYP2C and CYP2B mediated metabolic activation of retrorsine in CYP3A knockout mice. Curr Drug Metab. 21(13):1040–1051.
   PubMed Web of Science ®Google Scholar
• Roeder E. 2000. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie. 55(10):711–726.
   PubMed Web of Science ®Google Scholar
• Smith RB, Kroboth PD, Phillips JP. 1986. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration. J Clin Pharmacol. 26(2):120–124.
   PubMed Web of Science ®Google Scholar
• Takahashi JS. 2017. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 18(3):164–179.
   PubMed Web of Science ®Google Scholar
• Tamta H, Pawar RS, Wamer WG, Grundel E, Krynitsky AJ, Rader JI. 2012. Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates. Xenobiotica. 42(10):1038–1048.
   PubMed Web of Science ®Google Scholar
• Taylor DW, Wilson DW, Lamé MW, Dunston SD, Jones AD, Segall HJ. 1997. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells. Toxicol Appl Pharmacol. 143(1):196–204.
   PubMed Web of Science ®Google Scholar
• Tong Y, Zeng P, Zhang T, Zhao M, Yu P, Wu B. 2019. The transcription factor E4bp4 regulates the expression and activity of CYP3A11 in mice. Biochem Pharmacol. 163:215–224.
   PubMed Web of Science ®Google Scholar
• Tu ZB, Konno C, Soejarto DD, Waller DP, Bingel AS, Molyneux RJ, Edgar JA, Cordell GA, Fong HH. 1988. Identification of senecionine and senecionine N-oxide as antifertility constituents in Senecio vulgaris. J Pharm Sci. 77(5):461–463.
   PubMed Web of Science ®Google Scholar
• Wiedenfeld H, Edgar J. 2011. Toxicity of pyrrolizidine alkaloids to humans and ruminants. Phytochem Rev. 10(1):137–151.
   Web of Science ®Google Scholar
• Yang X, Li W, Sun Y, Guo X, Huang W, Peng Y, Zheng J. 2017. Comparative study of hepatotoxicity of pyrrolizidine alkaloids retrorsine and monocrotaline. Chem Res Toxicol. 30(2):532–539.
   PubMed Web of Science ®Google Scholar
• Yao J, Li CG, Gong LK, Feng CC, Li CZ, Gao M, Luan Y, Qi XM, Ren J. 2014. Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice. Acta Pharmacol Sin. 35(2):292–300.
   PubMed Web of Science ®Google Scholar
• Zhang T, Yu F, Guo L, Chen M, Yuan X, Wu B. 2018. Small heterodimer partner regulates circadian cytochromes p450 and drug-induced hepatotoxicity. Theranostics. 8(19):5246–5258.
   PubMed Web of Science ®Google Scholar
• Zhao H, Tong Y, Lu D, Wu B. 2020. Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism. J Pharm Pharmacol. 72(12):1854–1864.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhao H, Deng J, Guo L, Wu B. 2019. Role of the clock protein in liver detoxification. Br J Pharmacol. 176(24):4639–4652.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Xue CC, Yu XQ, Wang G. 2007. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab. 8(6):526–553.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Lin Y, Gao L, Yang Z, Wang S, Wu B. 2019. CYP3A11 metabolism-based chronotoxicity of brucine in mice. Toxicol Lett. 313:188–195.
   PubMed Web of Science ®Google Scholar